TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/09/2024
Voltar para busca
Dado oficial do USPTO
ACCREDO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ACCREDO
ST13
US500000077353861Classe
35, 41, 42, 44
Pedido
77353861
Registro
3677262
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
01/10/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 44
Data de depósito
17/12/2007
Data de registro
01/09/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/10/2019
Última transação
01/10/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
18/10/2008
Primeiro uso no comércio
18/10/2008
Código do desenho
4
Tipo de titular
03
Localização do titular
ST. LOUIS, MO
Examinador
SHANAHAN, PATRICK
Unidade examinadora
M70
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
Accredo Health Group, Inc.
Representantes
Troy E. Larson
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia
Classe 41
Providing patient educational servicesconducting programs in the field of chronic diseaseproper product-reconstitution and administrationresources appropriate for support of disease management; educational services for product manufacturerspharmaceutical clinicians and biotech companiesclinicianscontract research organizations and insurance providersconducting classesone-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational servicesclassesone on one sessions and telephonic workshops which provide physiciansinsurance companies and patients with specific characteristics associated with disease management products; educational services and resourcesconducting workshops for children to help them understand hemophilia; educational servicesconducting workshops for children to help them understand hemophilia
Classe 42
Providing clinical research in the field of medicine for product manufacturerspharmaceutical and biotech companiescontract research organizations and insurance providersproviding consulting services in support of new drug product launches; medical serviceson-line analysis of infusion and bleeding activity for hemophiliacs
Classe 44
Nursing care specializing in the treatmentprevention and control of chronic diseases; nursing care specializing in the treatmentprevention and control of hemophilia; medical servicesadministration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counselingoffering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical servicesspecialized pharmaceutical advice for individuals with bleeding disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/09/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/10/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/10/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/10/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
27/08/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/09/2018
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/05/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
22/09/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
22/09/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/09/2015
E815
TEAS SECTION 8 & 15 RECEIVED
19/08/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/10/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/10/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2009
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
27/07/2009
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/07/2009
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/06/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/06/2009
IUAF
USE AMENDMENT FILED
13/05/2009
EISU
TEAS STATEMENT OF USE RECEIVED
13/05/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
18/11/2008
PUBO
PUBLISHED FOR OPPOSITION
26/08/2008
NPUB
NOTICE OF PUBLICATION
06/08/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/07/2008
ALIE
ASSIGNED TO LIE
22/07/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/07/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/07/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/07/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/07/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/03/2008
GNRT
NON-FINAL ACTION E-MAILED
24/03/2008
CNRT
NON-FINAL ACTION WRITTEN
24/03/2008
DOCK
ASSIGNED TO EXAMINER
24/03/2008
NWAP
NEW APPLICATION ENTERED
20/12/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACCREDO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.